Life Science Matters An inside look at the latest legal developments involving medical devices, pharmaceuticals, and more

  • Home
  • About
  • Categories
    • ANDA
    • Class Action
    • Coronavirus
    • Daubert
    • Design Defect
    • FDA
    • IP
    • Labeling
    • Medical Device
    • News
    • Nutritional Supplements
    • Off Label
    • Pharmacy
    • Pharmaceuticals
    • Preemption
    • Recalls
    • Regulatory
    • Sales Representatives
    • Settlements
    • Supplements
    • Verdicts
  • Resources
  • Subscribe
  • Contact Us

This Week’s Life Science Headlines

  • January 16, 2014
  • /
  • Class Action FDA Litigation News Pharmaceuticals Product Liability Recalls Regulatory
  • /
  • Life Science Matters
        Litigation
  • Roche Loses Last Shot at Booting NJ Accutane Judge (subscription required)
  • NuvaRing Lawsuits Remain on Hold, as Trial Date Cancelled
  • Pfizer Faces Whistleblower Suit Over Lipitor Marketing (subscription required)
  • Forest Can’t Nix Mo. Class In Antidepressant Marketing MDL (subscription required)
  • Third Bellwether Trial in Bard Avaulta Mesh Litigation Delayed Indefinitely
  • 8th Circ. Affirms Novartis Loss in Aredia, Zometa Suit (subscription required)
  • NJ High Court Stays Accutane Case, Weighs Judge’s Recusal (subscription required)
Regulatory
  • FDA to Reopen Comment Period on
…
Continue reading...
  • 8th Circuit Affirms Novartis loss Accutane accutane case recusal acetaminophen additives antidepressant marketing lawsuit Aredia Avaulta mesh litigation bellwether bard mesh litigation blood glucose meters compounding pharmacies discontinue prescribing acetaminophen FDA investigational new drug application Lipitor lawsuit Lipitor marketing lawsuit Liptruzet recall new beverage guidelines New Jersey judge on Accutane case NuvaRing lawsuits Pfizer lawsuit Puritan Bennett 840 ventilator recall regulatory Roche social media rules supplements Tandem t:cell insulin recall Zometa lawsuit
Goldberg Segalla

Search

Categories

  • Posts
  • Multicounty Litigation Order in New Jersey Provides No Guidance to Practitioners June 23, 2021
  • New Multicounty Litigation Application in New Jersey June 8, 2021
  • Lack of Agreement to Arbitrate Dooms Bid to Compel Arbitration May 26, 2021
  • Mixed Bag in New Jersey Medical Device Preemption Opinion May 12, 2021
  • First Circuit Agrees Pharmacists Provide Services, Not Sell Goods April 27, 2021

About Us

Goldberg Segalla is a national civil litigation firm with more than 20 offices in 10 states spanning major metro markets across the U.S., providing strategic coverage wherever our clients do business. As a firm of experienced litigators and trial attorneys, our capabilities span business and commercial disputes, employment and labor, insurance coverage, product liability, and more. Today, our nearly 400 attorneys are trusted counselors to public and private clients in key sectors and industries including construction and energy, transportation, manufacturing, retail and hospitality, and insurance.

Links

  • Home
  • About
  • Resources
  • Contact Us
Copyright 2023 · Goldberg Segalla